Clinical Trial

Neoadjuvant Adebrelimab Plus Chemotherapy for Esophageal Cancer: A Clinical Study

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated February 27, 2026 (before its estimated April 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a domestic exploratory, single-arm clinical study enrolling patients with histologically or cytologically confirmed locally advanced esophageal squamous cell carcinoma (ESCC), aiming to evaluate the efficacy and safety of neoadjuvant adebrelimab plus chemotherapy for locally advanced esophageal squamous cell carcinoma (ESCC).
Trial Details
NCT Number NCT07437898
Lead Sponsor The Affiliated Hospital of Putian University
Conditions Esophageal Squamous Cell Carcinoma
Enrollment 42 participants
Start Date 2024-09-03
Primary Completion 2026-04-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-27